Similar articles

• [Axillary hyperhidrosis].

  Petzoldt D, Lamminger C. Petzoldt D, et al. Dtsch Med Wochenschr. 1992 Aug 28;117(35):1339. Dtsch Med Wochenschr. 1992. PMID: 1505357 German. No abstract available.
• Botulinum toxin type a versus topical 20% aluminum chloride for the treatment of moderate to severe primary focal axillary hyperhidrosis.

  Flanagan KH, King R, Glaser DA. Flanagan KH, et al. J Drugs Dermatol. 2008 Mar;7(3):221-7. J Drugs Dermatol. 2008. PMID: 18380203 Clinical Trial.
• An open-label trial of the efficacy of 15% aluminum chloride in 2% salicylic acid gel base in the treatment of moderate-to-severe primary axillary hyperhidrosis.

  Flanagan KH, Glaser DA. Flanagan KH, et al. J Drugs Dermatol. 2009 May;8(5):477-80. J Drugs Dermatol. 2009. PMID: 19537371 Clinical Trial.
• Pathophysiology and Treatment of Hyperhidrosis.

  Fujimoto T. Fujimoto T. Curr Probl Dermatol. 2016;51:86-93. doi: 10.1159/000446786. Epub 2016 Aug 30. Curr Probl Dermatol. 2016. PMID: 27584967 Review.
• Current therapeutic strategies for hyperhidrosis: a review.

  Togel B, Greve B, Raulin C. Togel B, et al. Eur J Dermatol. 2002 May-Jun;12(3):219-23. Eur J Dermatol. 2002. PMID: 11978559 Review.